Rice Hall James & Associates LLC Has $5.31 Million Stock Position in Aspen Aerogels, Inc. $ASPN

Rice Hall James & Associates LLC increased its stake in Aspen Aerogels, Inc. (NYSE:ASPN) by 9.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,552,628 shares of the construction company’s stock after purchasing an additional 131,023 shares during the period. Rice Hall James & Associates LLC owned approximately 1.87% of Aspen Aerogels worth $5,310,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. grew its stake in Aspen Aerogels by 0.5% during the third quarter. Vanguard Group Inc. now owns 4,510,370 shares of the construction company’s stock worth $31,392,000 after buying an additional 22,686 shares in the last quarter. Needham Investment Management LLC increased its holdings in Aspen Aerogels by 26.5% in the 4th quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock valued at $12,315,000 after buying an additional 912,000 shares during the period. Invesco Ltd. raised its position in shares of Aspen Aerogels by 237.9% in the 4th quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock valued at $11,688,000 after buying an additional 2,907,558 shares in the last quarter. State Street Corp raised its position in shares of Aspen Aerogels by 28.6% in the 4th quarter. State Street Corp now owns 2,501,469 shares of the construction company’s stock valued at $7,079,000 after buying an additional 556,833 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Aspen Aerogels by 1.1% during the 4th quarter. Geode Capital Management LLC now owns 1,602,049 shares of the construction company’s stock worth $4,535,000 after acquiring an additional 17,178 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on ASPN shares. Wall Street Zen upgraded shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Barclays boosted their price objective on shares of Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a research report on Monday, May 11th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Finally, Roth Capital reaffirmed a “buy” rating and issued a $5.75 target price on shares of Aspen Aerogels in a report on Friday, May 8th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $5.19.

Aspen Aerogels Stock Down 9.6%

Shares of NYSE ASPN opened at $4.67 on Friday. The company has a market cap of $386.64 million, a price-to-earnings ratio of -3.43 and a beta of 2.98. The company has a current ratio of 2.89, a quick ratio of 2.54 and a debt-to-equity ratio of 0.32. Aspen Aerogels, Inc. has a 12 month low of $2.30 and a 12 month high of $9.78. The stock has a 50-day moving average price of $5.66 and a two-hundred day moving average price of $4.31.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Thursday, May 7th. The construction company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The company had revenue of $37.88 million for the quarter, compared to the consensus estimate of $36.58 million. Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The company’s revenue for the quarter was down 51.8% compared to the same quarter last year. During the same period last year, the firm posted ($0.06) earnings per share. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. As a group, analysts forecast that Aspen Aerogels, Inc. will post -0.8 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.